Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells

Sharyl J. Nass, Anne T. Ferguson, Dorraya El-Ashry, William G. Nelson, Nancy E. Davidson

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Estrogen receptor (ER)-negative breast cancer cells display extensive methylation of the ER gene CpG island and elevated DNA methyltransferase (DMT) expression compared to ER-positive cells. The present study demonstrates that DMT protein levels tightly correlate with S phase fraction in ER-positive cells, whereas ER-negative cells express DMT throughout the cell cycle. In addition, levels of p21(CIP1), which disrupts DMT binding to PCNA, are inversely correlated with DMT levels. Therefore increased DMT expression in ER-negative cells is not simply due to elevated S-phase fraction, but rather to more complex changes that allow cells to escape normal cell cycle-dependent controls on DMT expression. Because ER-negative breast tumors often have activated growth factor pathways, the impact of these pathways on DMT expression was examined in ER-positive cells. Stable transfection with fibroblast growth factors (FGFs) 1 and 4 led to increased DMT expression that could not be accounted for by a shift in S phase fraction. Elevated DMT protein expression in FGF-transfectants was accompanied by a significant decrease in p21, again suggesting a reciprocal relationship between these two proteins. However, acquisition of an estrogen-independent phenotype, even in conjunction with elevated DMT levels, was not sufficient to promote ER gene silencing via methylation. These results indicate that multiple steps are required for de novo methylation of the ER CpG island.

Original languageEnglish
Pages (from-to)7453-7461
Number of pages9
JournalOncogene
Volume18
Issue number52
StatePublished - Dec 9 1999
Externally publishedYes

Fingerprint

Transferases
Estrogen Receptors
Cell Cycle
Breast Neoplasms
DNA
S Phase
Methylation
CpG Islands
Fibroblast Growth Factor 4
Fibroblast Growth Factor 1
Proteins
Fibroblast Growth Factors
Proliferating Cell Nuclear Antigen
Methyltransferases
Gene Silencing
Cell Cycle Checkpoints
Transfection
Intercellular Signaling Peptides and Proteins
Estrogens
Phenotype

Keywords

  • Breast cancer
  • DNA methylation
  • Estrogen receptor
  • p21
  • S phase

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Nass, S. J., Ferguson, A. T., El-Ashry, D., Nelson, W. G., & Davidson, N. E. (1999). Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells. Oncogene, 18(52), 7453-7461.

Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells. / Nass, Sharyl J.; Ferguson, Anne T.; El-Ashry, Dorraya; Nelson, William G.; Davidson, Nancy E.

In: Oncogene, Vol. 18, No. 52, 09.12.1999, p. 7453-7461.

Research output: Contribution to journalArticle

Nass, SJ, Ferguson, AT, El-Ashry, D, Nelson, WG & Davidson, NE 1999, 'Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells', Oncogene, vol. 18, no. 52, pp. 7453-7461.
Nass SJ, Ferguson AT, El-Ashry D, Nelson WG, Davidson NE. Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells. Oncogene. 1999 Dec 9;18(52):7453-7461.
Nass, Sharyl J. ; Ferguson, Anne T. ; El-Ashry, Dorraya ; Nelson, William G. ; Davidson, Nancy E. / Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells. In: Oncogene. 1999 ; Vol. 18, No. 52. pp. 7453-7461.
@article{3e64bff87691400481968611d5c0e401,
title = "Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells",
abstract = "Estrogen receptor (ER)-negative breast cancer cells display extensive methylation of the ER gene CpG island and elevated DNA methyltransferase (DMT) expression compared to ER-positive cells. The present study demonstrates that DMT protein levels tightly correlate with S phase fraction in ER-positive cells, whereas ER-negative cells express DMT throughout the cell cycle. In addition, levels of p21(CIP1), which disrupts DMT binding to PCNA, are inversely correlated with DMT levels. Therefore increased DMT expression in ER-negative cells is not simply due to elevated S-phase fraction, but rather to more complex changes that allow cells to escape normal cell cycle-dependent controls on DMT expression. Because ER-negative breast tumors often have activated growth factor pathways, the impact of these pathways on DMT expression was examined in ER-positive cells. Stable transfection with fibroblast growth factors (FGFs) 1 and 4 led to increased DMT expression that could not be accounted for by a shift in S phase fraction. Elevated DMT protein expression in FGF-transfectants was accompanied by a significant decrease in p21, again suggesting a reciprocal relationship between these two proteins. However, acquisition of an estrogen-independent phenotype, even in conjunction with elevated DMT levels, was not sufficient to promote ER gene silencing via methylation. These results indicate that multiple steps are required for de novo methylation of the ER CpG island.",
keywords = "Breast cancer, DNA methylation, Estrogen receptor, p21, S phase",
author = "Nass, {Sharyl J.} and Ferguson, {Anne T.} and Dorraya El-Ashry and Nelson, {William G.} and Davidson, {Nancy E.}",
year = "1999",
month = "12",
day = "9",
language = "English",
volume = "18",
pages = "7453--7461",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "52",

}

TY - JOUR

T1 - Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells

AU - Nass, Sharyl J.

AU - Ferguson, Anne T.

AU - El-Ashry, Dorraya

AU - Nelson, William G.

AU - Davidson, Nancy E.

PY - 1999/12/9

Y1 - 1999/12/9

N2 - Estrogen receptor (ER)-negative breast cancer cells display extensive methylation of the ER gene CpG island and elevated DNA methyltransferase (DMT) expression compared to ER-positive cells. The present study demonstrates that DMT protein levels tightly correlate with S phase fraction in ER-positive cells, whereas ER-negative cells express DMT throughout the cell cycle. In addition, levels of p21(CIP1), which disrupts DMT binding to PCNA, are inversely correlated with DMT levels. Therefore increased DMT expression in ER-negative cells is not simply due to elevated S-phase fraction, but rather to more complex changes that allow cells to escape normal cell cycle-dependent controls on DMT expression. Because ER-negative breast tumors often have activated growth factor pathways, the impact of these pathways on DMT expression was examined in ER-positive cells. Stable transfection with fibroblast growth factors (FGFs) 1 and 4 led to increased DMT expression that could not be accounted for by a shift in S phase fraction. Elevated DMT protein expression in FGF-transfectants was accompanied by a significant decrease in p21, again suggesting a reciprocal relationship between these two proteins. However, acquisition of an estrogen-independent phenotype, even in conjunction with elevated DMT levels, was not sufficient to promote ER gene silencing via methylation. These results indicate that multiple steps are required for de novo methylation of the ER CpG island.

AB - Estrogen receptor (ER)-negative breast cancer cells display extensive methylation of the ER gene CpG island and elevated DNA methyltransferase (DMT) expression compared to ER-positive cells. The present study demonstrates that DMT protein levels tightly correlate with S phase fraction in ER-positive cells, whereas ER-negative cells express DMT throughout the cell cycle. In addition, levels of p21(CIP1), which disrupts DMT binding to PCNA, are inversely correlated with DMT levels. Therefore increased DMT expression in ER-negative cells is not simply due to elevated S-phase fraction, but rather to more complex changes that allow cells to escape normal cell cycle-dependent controls on DMT expression. Because ER-negative breast tumors often have activated growth factor pathways, the impact of these pathways on DMT expression was examined in ER-positive cells. Stable transfection with fibroblast growth factors (FGFs) 1 and 4 led to increased DMT expression that could not be accounted for by a shift in S phase fraction. Elevated DMT protein expression in FGF-transfectants was accompanied by a significant decrease in p21, again suggesting a reciprocal relationship between these two proteins. However, acquisition of an estrogen-independent phenotype, even in conjunction with elevated DMT levels, was not sufficient to promote ER gene silencing via methylation. These results indicate that multiple steps are required for de novo methylation of the ER CpG island.

KW - Breast cancer

KW - DNA methylation

KW - Estrogen receptor

KW - p21

KW - S phase

UR - http://www.scopus.com/inward/record.url?scp=0033539922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033539922&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 7453

EP - 7461

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 52

ER -